Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

By C. Salgado, B. Farr, D. Calfee. Clinical Infectious Diseases, 2003

842 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Infectious Diseases, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/03ad1f551882f6a20130db9f29fc4d71bad86bbf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

In Infectious Diseases

In Public Health, Environmental and Occupational Health

Citations in the corpus

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic (2010, background): “This sometimes loose interchange of terms has created confusion (216, 606, 796, 878).”
The evolution of Staphylococcus aureus. (2008, background): “CA-MRSA is defined in several ways (Naimi et al., 2003; Salgado et al., 2003).”
The molecular evolution of methicillin-resistant Staphylococcus aureus. (2007, background): “[95] performed a global analysis of 57 studies on CA-MRSA prevalence among hospitalised patients and individuals in the community, and found that most individuals with CA-MRSA had at least one riskfactor for MRSA.”
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005 (2007, positive): “Previous hospitalization has been associated with community MRSA carriage ( 22 ), and some recent studies have suggested that MRSA infection rates in the community are positively correlated with S . aureus infection rates in the hospital ( 23 , 24 ).”
Pulsed-Field Gel Electrophoresis Typing of Oxacillin-Resistant Staphylococcus aureus Isolates from the United States: Establishing a National Database (2003, background): “laboratories), is a frequent cause of infections both in health care and community settings and is endemic in many U.S. hospitals (12, 26, 27, 32, 48, 56 ).”
Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. (2006, background): “aureus bloodstream infections that are meticillin resistant is small(9) (under 1%) compared with Germany (19%), Belgium (28%), France (33%), the USA (50%) and the UK (40%).(9,10) The low rates in some northern European countries may reflect a more vigorous ‘search and destroy’ policy combined with l”